[在2024年为马匹和生产动物提供新药]
Christin Jana Kamutzki1, Ilka Ute Emmerich1
1Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät der Universität Leipzig.
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere
|April 15, 2025
概括
2024年,德国兽医市场没有为马或食用动物提供新的药物. 创新包括蜜蜂的酸,马的克伦布醇,以及牛,和猪的新型疫苗.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 动物健康 动物健康
- 药品制造业 药品制造业 药品制造业 药品制造业
背景情况:
- 德国兽医药品市场在2024年没有针对马匹和粮食生产动物的新药剂.
- 在此期间,现有的活性成分没有扩展到新的动物物种.
研究的目的:
- 记录2024年在德国市场上推出的新兽药和创新.
- 突出各种动物种类的治疗和疫苗接种方面的进展.
主要方法:
- 审查2024年在德国发布的新制药和免疫兽医药品.
- 根据动物物种和治疗领域对新产品的分类.
主要成果:
- 酸被批准用于短期治疗蜜蜂;克伦布醇可作为马的口服溶液.
- 推出了三种新的疫苗: *Cryptosporidium parvum*和 *Mycoplasma bovis*用于牛,以及禽流感 (H9亚型) 用于.
- 对于猪来说,新的疫苗包括猪肉病毒 (类型2d),呼吸道病原体组合 (无针应用于) 和*Actinobacillus pleuropneumoniae* (血清11组合). 新的三价疫苗和腹病原体组合也获得批准.
- 对于来说,一种新的重组疫苗针对传染性炎,传染性喉炎和马雷克病.
- 为牛冠状病毒 (鼻腔) 和猪病毒/*Mycoplasma hyopneumoniae* (无针) 疫苗引入了新的施用方法.
结论:
- 2024年德国兽医市场的重点是特定的新疗法和先进的免疫产品,而不是广泛的新药批准.
- 创新包括对现有物质的新应用,新型疫苗配方,以及改善主要牲畜和家禽疾病的输送系统.
更多相关视频
相关概念视频
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
Drug Discovery: Overview
7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
Prescription, Nonprescription and Orphan Drugs
658
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
658
Drug Nomenclature
1.5K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.5K


